[Retracted] Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population

Table 3

Genotype distribution of SNPs in BCa patients and control groups.

Gene	SNPs	Genotype	BCa patients	Control groups	OR (95% CI)	value
SLC15A1	rs2297322	CC	275	335	—	—
		CT	167	191	1.065 (0.820–1.384)	0.637
		TT	45	37	1.482 (0.932–2.355)	0.095
		CT + TT	212	228	1.133 (0.886–1.448)	0.320
	rs4646227	CC	301	453	—	—
		CG	167	100	2.513 (1.885–3.351)	0.001
		GG	19	10	2.859 (1.311–6.235)	0.006
		CG + GG	186	110	2.545 (1.929–3.358)	0.001
	rs1289389	CC	271	317	—	—
		CT	184	206	1.045 (0.808–1.350)	0.738
		TT	32	40	0.936 (0.572–1.531)	0.792
		CT + TT	216	246	1.027 (0.804–1.311)	0.830
UGT1A3	rs3821242	TT	247	304	—	—
		TC	198	218	1.118 (0.866–1.443)	0.392
		CC	42	41	1.261 (0.794–2.001)	0.325
		TC + CC	240	259	1.140 (0.894–1.454)	0.289
	rs6431625	TT	360	435	—	—
		TC	111	118	1.137 (0.847–1.526)	0.394
		CC	16	10	1.933 (0.867–4.313)	0.102
		TC + CC	127	128	1.199 (0.904–1.590)	0.208
	rs10929303	CC	308	367	—	—
		CT	142	167	1.013 (0.773–1.327)	0.924
		TT	37	29	1.520 (0.914–2.530)	0.105
		CT + TT	179	196	1.088 (0.845–1.401)	0.512
CWC27	rs2042329	GG	323	416	—	—
		GT	142	136	1.345 (1.020–1.773)	0.035
		TT	22	11	2.576 (1.231–5.389)	0.009
		GT + TT	164	147	1.437 (1.101–1.874)	0.007
	rs7735338	CC	151	161	—	—
		CG	238	294	0.863 (0.652–1.142)	0.303
		GG	98	108	0.968 (0.680–1.376)	0.854
		CG + GG	336	402	0.891 (0.684–1.162)	0.394
	rs1870437	CC	310	400	—	—
		CT	148	145	1.317 (1.003–1.730)	0.048
		TT	29	18	2.079 (1.133–3.813)	0.016
		CT + TT	177	163	1.401 (1.081–1.816)	0.011
	rs2278351	TT	115	139	—	—
		TC	259	301	1.040 (0.772–1.401)	0.796
		CC	113	123	1.110 (0.778–1.584)	0.563
		TC + CC	372	424	1.060 (0.799–1.408)	0.685